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In this issue of the European Journal of Human Genetics, Arteche-
Lopez et al. describe novel phenotypes associated with bi-allelic
variants in genes previously linked with a dominant mode of
inheritance [1]. A homozygous protein-truncating variant in
CACNA1A was identified in four infants presenting with
hypotonia and epileptic encephalopathy. A number of diseases
are associated with heterozygous CACNA1A variants: spinocer-
ebellar ataxia with a trinucleotide expansion in the gene and
episodic ataxias and migraine with single nucleotide variants.
Both parents were heterozygous for the CACNA1A variants and
had compatible neurological phenotypes. The severe phenotype
in the children was postulated to relate to homozygous
inheritance [1].
In a boy with Hirschsprung disease, a homozygous missense
variant in RET was identified. RET gain of function variants is
associated with multiple endocrine neoplasia, while heterozygous
loss of function variants are the major risk gene for Hirschsprung
disease. Neither heterozygous parent was symptomatic, perhaps
because of the known reduced penetrance of RET loss of function
variants [1].
A 55-year-old woman with primary basal ganglia calcification
was identified to have a homozygous missense variant in
SLC20A2. Segregation analysis suggested possible codominant
inheritance, with some possibly affected heterozygotes [1].
The families reported in this paper were consanguineous; which
increased the chance of bi-allelic inheritance of these autosomal
dominant genes, and led to the identification of the associated bi-
allelic phenotype. However, the principle that bi-allelic inheritance
of autosomal dominant (i.e., a phenotype with heterozygous state)
genes can be associated with a disease phenotype applies in
general to clinical interpretation of genome sequencing. It also
needs to be borne in mind when interpreting family histories and
offering genetic counselling.
Bi-allelic inheritance of a number of autosomal dominant genes
has been reported, and it is important for clinicians to be aware of
these. This is increasingly recognised in rare neurodevelopmental
disorders. Recently, variants in SLC12A2 have been associated with
both heterozygous and bi-allelic modes of inheritance [2]. Both
heterozygous and bi-allelic variants in SLC12A2 have been reported
in association with neurodevelopmental disorders of varying
severity. With homozygous variants being associated with a
generally more severe phenotype. This provides further evidence
of a gene dosage effect underlying genotype–phenotype
correlations in such families. Interestingly, both monoallelic and bi-
allelic variants in TET3 can cause a neurodevelopmental disorder [3].
This could be explained by monoallelic variants being loss of
function, while the bi-allelic variants were missense variants. The
dominance or recessivity of a variant might be determined by the
severity of the impact of the variant on protein stability or function.
Sometimes the phenotype in heterozgyous carriers and those with
bi-allelic variants can appear unrelated. For example, monoallelic
missense WDR11 variants are linked to hypogonadotrophic hypo-
gonadism while bi-allelic loss of function variants present with a
neurodevelopmental disorder [4]. It is possible that in different
regions of the developing brain (e.g., hypothalamus-pituitary) a gene
is haploinsufficient while in other regions (e.g., the cerebral cortex)
there is no requirement for bi-allelic function of the gene.
Dual modes of inheritance are also relevant for common
diseases. Bi-allelic variants in the GBA1 gene are associated with
Gaucher disease [5]. Both heterozygous carriers of GBA1 variants
and people with Gaucher disease have an increased chance of
developing Parkinson’s disease. It has been postulated that this is
due to reduced glucocerebrosidase enzyme activity associated
with reduced lysosomal degradation of alpha-synuclein in both
heterozygous and bi-allelic states. But that only severe reduction
in enzymatic activity associated with bi-allelic variants leads to the
more widespread clinical manifestations of Gaucher disease. Clear
evidence of genotype-phenotype correlations due to gene dosage
effects.
The considerations outlined above are also relevant in cancer
genetics. Heterozygous variants in neurofibromin gene are
associated with neurofibromatosis type 1, a rare neurocutaneous
syndrome [6]. Inheritance of bi-allelic neurofibromin gene variants
leads to a multiple primary neoplasia syndrome. This might
present in paediatric oncology with unusual combinations of solid
and haematological malignancies, the clinical clues to the genetic
aetiology being presences of cafe-au-lait macules in the proband
and possibly (sub)clinical neurofibromatosis type 1 in the parents.
Ataxia telangiectasia is associated with bi-allelic ATM variants.
However, heterozygous ATM variants increase breast cancer risk in
carriers [7]. This should be considered when managing families
affected by ataxia telangiectasia.
The research work described in this comment has clear
implications for clinical practice. Clinicians should be aware of
the expanding list of genes for which both dominant and
recessive modes of inheritance operate. Clinicians, researchers,
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and bioinformaticians should consider the possibility of pre-
viously unrecognised phenotypes due to bi-allelic inheritance
of dominant genes, or manifestations in heterozygous carriers
of genes previously classified as autosomal recessive. The
mechanisms underlying dual modes of inheritance warrant
further study.
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